Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Moderna And 3 Other Stocks Insiders Are Selling

Published 16/05/2022, 14:01
Updated 16/05/2022, 14:40
© Reuters.  Moderna And 3 Other Stocks Insiders Are Selling

US crude oil futures traded lower, dropping around 0.5% on Monday. Investors, meanwhile, focused on some notable insider trades.

When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to go short on the stock. Insider sales should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a selling decision.

Below is a look at a few recent notable insider sales. For more, check out Benzinga's insider transactions platform.

Moderna (NASDAQ:MRNA)

  • The Trade: Moderna, Inc. (NASDAQ: MRNA) Director Noubar B. Afeyan sold a total of 310,000 shares at an average price of $131.79. The insider received around $40.86 million from selling those shares.
  • What’s Happening: Moderna announced that its recently appointed Chief Financial Officer, Jorge Gomez, has departed the company, effective immediately.
  • What Moderna Does: Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018.
ABC
  • The Trade: AmerisourceBergen Corporation (NYSE: ABC) 10% owner Walgreens Boots Alliance (NASDAQ:WBA) Holdings Llc sold a total of 6,000,000 shares at an average price of $150.00. The insider received around $900 million from selling those shares.
  • What’s Happening: Walgreens Boots Alliance reached a $683 million settlement with Florida to resolve claims that the pharmacy chain exacerbated an opioid epidemic in the state.
  • What AmerisourceBergen Does: AmerisourceBergen is a leading pharmaceutical wholesaler engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Murphy USA

  • The Trade: Murphy USA Inc. (NYSE: MUSA) Director Madison Robert Murphy sold a total of 40,000 shares at an average price of $239.52. The insider received around $9.58 million as a result of the transaction.
  • What’s Happening: Murphy USA posted Q1 earnings of $6.08 per share.
  • What Murphy USA Does: Murphy USA Inc is an American retailer of gasoline products and convenience-store merchandise operating in the United States.

Credit Acceptance

  • The Trade: Credit Acceptance Corporation (NASDAQ: CACC) Director Thomas Smith sold a total of 14,648 shares at an average price of $587.29. The insider received around $8.6 million from selling those shares.
  • What’s Happening: Credit Acceptance recently reported better-than-expected Q1 results.
  • What Credit Acceptance Does: Credit Acceptance Corp is a consumer finance company that specializes in automobile loans.

Read at Benzinga

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.